Страна: Ирландия
Язык: английский
Источник: HPRA (Health Products Regulatory Authority)
Amoxicillin ; Clavulanic acid
Le Vet Beheer B.V.
QJ01CR02
Amoxicillin ; Clavulanic acid
50, 12.5 mg/tablet
Tablet
POM: Prescription Only Medicine as defined in relevant national legislation
Dogs, Cats
amoxicillin and enzyme inhibitor
Antibacterial
Authorised
2013-11-08
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Clavubactin 50/12.5 mg tablets for cats and dogs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Tablets. Yellowish-white to light yellow round tablet with a cross-shaped break mark on one side. The tablets can be divided into 4 equal parts. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and cats 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of infections in cats and dogs caused by bacteria sensitive to amoxicillin in combination with clavulanic acid, particularly: - Skin infections (including superficial and deep pyodermas) associated with Staphylococci (including beta-lactamase producing strains) and Streptococci. - Urinary tract infections associated with Staphylococci (including beta-lactamase producing strains), Streptococci, _Escherichia coli_ (including beta-lactamase producing strains),_ Fusobacterium necrophorum_ and_ Proteus_ spp. - Respiratory tract infections associated with Staphylococci (including beta-lactamase producing strains), Streptococci and Pasteurellae. - Gastrointestinal tract infections associated with_ Escherichia coli_ (including beta-lactamase producing strains) and _Proteus_ spp. - Infections of the oral cavity (mucous membrane) associated with Clostridia, Corynebacteria, Staphylococci (including beta-lactamase producing strains), Streptococci,_ Bacteroides_ spp. (including beta-lactamase producing strains),_ Fusobacterium necrophorum_ and Pasteurellae. Each tablet contains: ACTIVE SUBSTANCES: _quantity_ Amoxicillin (as amoxicillin trihydrate) 50 mg Clavulanic acid (as potassium clavulanate) 12.5 mg EXCIPIENT(S): Quinoline Yellow E104 0.06 mg Titanium dioxide E171 0.10 mg For the full list of excipients, see section 6.1. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ __ Прочитать полный документ